Showing results (201-210 of 402) with videos related to
Sort By:
Pageof 41
The Journal of Biological Chemistry|July 10, 1984
Phosphorylation of mammalian myosin light chain kinases by the catalytic subunit of cyclic AMP-dependent protein kinase and by cyclic GMP-dependent protein kinaseM Nishikawa, P de Lanerolle, T M Lincoln, et al.Schizophrenia Research|September 5, 2019
Fostering coping as a mechanism of symptom change in cognitive behavioural therapy for psychosisBjörn Schlier, Lea Ludwig, Martin Wiesjahn, et al.MMWR. Morbidity and Mortality Weekly Report|May 29, 2015
Occupational fatalities during the oil and gas boom--United States, 2003-2013Krystal L Mason, Kyla D Retzer, Ryan Hill, et al.MMWR. Morbidity and Mortality Weekly Report|April 28, 2017
Occupational Fatalities Resulting from Falls in the Oil and Gas Extraction Industry, United States, 2005-2014Krystal L Mason, Kyla D Retzer, Ryan Hill, et al.Psychological Medicine|December 23, 2021
Predictors of successful discontinuation of antipsychotics and antidepressantsTania M Lincoln, Daniel Sommer, Mariana Quazzola, et al.Cardiovascular Research|November 10, 2012
Transcriptional and post-transcriptional regulation of cGMP-dependent protein kinase (PKG-I): pathophysiological significanceHassan Sellak, Chung-sik Choi, Nupur B Dey, et al.Schizophrenia Bulletin|May 12, 2009
The effect of state anxiety on paranoid ideation and jumping to conclusions. An experimental investigationTania M Lincoln, Jennifer Lange, Julia Burau, et al.Journal of Behavior Therapy and Experimental Psychiatry|September 19, 2016
Negative affect and a fluctuating jumping to conclusions bias predict subsequent paranoia in daily life: An online experience sampling studyThies Lüdtke, Levente Kriston, Johanna Schröder, et al.Pilot and Feasibility Studies|May 2, 2023
"Goals in Focus"-a targeted CBT approach for motivational negative symptoms of psychosis: study protocol for a randomized-controlled feasibility trialAlisa L A Schormann, Matthias Pillny, Katharina Haß, et al.Schizophrenia Research and Treatment|April 3, 2014
Explaining attitudes and adherence to antipsychotic medication: the development of a process modelMartin Wiesjahn, Esther Jung, Fabian Lamster, et al.Pageof 41